AUNA S.A. - AUNA STOCK NEWS

Auna S.A. (NYSE: AUNA), a Latin American healthcare company operating in Mexico, Peru and Colombia, has announced the completion of a private placement of USD 57.8 million in 10.000% Senior Secured Notes due 2029. The proceeds were used to fully redeem its existing 6.500% Senior Secured Notes due 2025, at a redemption price of 101.625% plus interest. These Additional 2029 Notes were issued under the same indenture as the company's outstanding USD 253 million 10.000% Senior Secured Notes from December 2023, bringing the total outstanding amount to USD 310.8 million.

Auna (NYSE: AUNA), a leading Latin American healthcare company, has appointed two new independent directors to its Board effective January 1, 2025. Teresa Gutierrez, currently responsible for Tesla in Mexico, and Guadalupe Phillips, CEO of ICA, will join the board, bringing the total member count to nine, including five independent directors.

Gutierrez brings 20 years of experience in e-commerce, logistics, and marketing, while Phillips contributes expertise in organic and inorganic growth along with financial acumen. Both appointees hold multiple board positions across various companies and bring diverse expertise to support Auna's expansion plans in Mexico and Latin America.

Auna (NYSE: AUNA) reported strong Q3 2024 financial results with consolidated revenue increasing 11% YoY to S/1,127 million. Adjusted EBITDA grew 18% YoY to S/250 million, with margin expanding 1.4 p.p. to 22.1%. The company improved its leverage ratio to 3.7x from 4.1x in Q2 2024. Net Income reached S/101 million, compared to a Net Loss of S/18 million in Q3 2023. Notable operational improvements include increased consolidated capacity utilization to 67% and improved Oncology Plan MLR at 53.7%. The company showed strong performance across its markets, with revenue growth of 16% in Mexico, 13% in Peru, and 11% in Colombia in local currency terms.

Auna (NYSE: AUNA), a Latin American healthcare services and plan provider operating in Mexico, Peru and Colombia, has scheduled its Third Quarter 2024 financial results announcement. The earnings release will be published after market close on Tuesday, November 19, 2024, followed by a conference call on Wednesday, November 20, 2024 at 8:00 a.m. ET. The company will observe a quiet period from November 11 through November 19, 2024.

Auna S.A. (NYSE: AUNA), a Latin American healthcare company, has appointed Laurent "Lorenzo" Massart as Executive Vice President, Strategy and Equity Capital Markets. With over 25 years of experience in consulting and investment banking, Massart brings valuable expertise to this newly created role. He has been a key advisor to Auna for the past three years, contributing to their expansion into Mexico and their transition to becoming a public company.

In his new position, Massart will oversee the Investor Relations function, ensuring a cohesive approach to communicating with investors and stakeholders. This appointment signals Auna's commitment to positioning senior talent in key roles and strengthening relationships with current and future investors.

Auna (NYSE: AUNA), a leading healthcare platform in Latin America, announced strong Q2 2024 financial results. Consolidated revenue increased 18% YoY to S/1,120 million, while Adjusted EBITDA rose 31% YoY to S/248 million. The company's Adjusted EBITDA margin expanded to 22.1%, up 2.0 percentage points YoY. Auna's leverage ratio improved to 4.13x from 4.89x in Q2 2023.

Key highlights include:

• Operating profit increased 34% YoY to S/183 million
• Net Income of S/8 million, compared to a Net loss of S/8 million in Q1 2024
• Launch of OncoMexico, the country's first integrated oncology insurance, in Monterrey

Auna's Executive Chairman emphasized the effectiveness of their business model and the company's progress in implementing the AunaWay in Monterrey. The company remains confident in achieving at least 20% FXN Adjusted EBITDA growth for the year.

Auna S.A. (NYSE: AUNA), a leading Latin American healthcare services and plan provider operating in Mexico, Peru, and Colombia, has announced its reporting schedule for Second Quarter 2024 financial results. The company will release its earnings report on Wednesday, August 21, 2024, after market close. A conference call is scheduled for the same day at 5:00 p.m. ET. Auna has also set a quiet period from August 2 to August 21, 2024. Interested parties can participate in the conference call via phone or webcast, with toll-free and international dial-in numbers provided.

Auna S.A. (NYSE: AUNA) has launched OncoSalud, the first integrated oncology insurance in Mexico, through its hospital network in Monterrey. This product, priced at an average of USD 40 per month, offers coverage up to USD 0.5 million annually for cancer prevention, detection, and treatment. It's designed for families with members up to 70 years old without pre-existing oncological conditions.

OncoSalud leverages Auna's 35 years of experience in Peru and Colombia, focusing on prevention and early detection with free preventive check-ups and diagnostic exams. The company estimates a total addressable market of up to 14 million people in Mexico, where cancer is the third leading cause of mortality. This initiative aims to transform access to oncology treatments and improve healthcare accessibility across the region.

Auna (NYSE: AUNA), a major player in Latin America's healthcare sector, announced its unaudited 1Q24 financial results. Revenue increased by 20% YoY to S/1,076 million, and operating profit rose by 26% to S/182 million. Adjusted EBITDA grew 14% YoY to S/241 million with a margin of 22.4%, though it decreased by 1.2 percentage points YoY. Net income improved to S/22 million from a break-even position in 1Q23.

Geographically, revenue growth was observed across all markets. In Peru, the adjusted EBITDA margin reached 20.4%, aligning with targets. Significant investments are being made in Mexico, particularly in Monterrey and the upcoming OncoMexico launch, expected to bolster returns in the latter half of 2024. The company forecasts adjusted EBITDA growth of 20% or more for the full year. The leverage ratio improved to 4.29x.

These financial results reflect Auna's integrated healthcare model's strength and its ability to generate substantial returns, emphasizing the company's commitment to modernizing healthcare in the region.